JP Morgan Maintains Overweight on United Therapeutics, Raises Price Target to $280
JP Morgan analyst Jessica Fung maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price target from $265 to $280.
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell
• Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.
Want To Copy ‘Master Trader’ Nancy Pelosi’s Investments? There’s An ETF For That. Here Are The Holdings
Subversive Capital launched two new ETFs Tuesday that offer investors the chance to mirror the trades being made by members of Congress.
The PTAB Denies United Therapeutics Request For A Rehearing Of The $UTHR ‘793 Patent Invalidation Decision
https://ptacts.uspto.gov/ptacts/public-informations/petitions/1545682/download-documents?artifactId=170521156
Alphabet And These 2 Healthcare Stocks Insiders Are Selling
The Nasdaq Composite dropped around 80 points on the first trading day of 2023. Investors, meanwhile, focused on some notable insider trades.
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
Gainers
Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session.
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.
United Therapeutics Posts Data From Remodulin Induction Before Orenitram Therapy In High Blood Pressure Patients
United Therapeutics Corp (NASDAQ:UTHR) announced a preliminary analysis of the EXPEDITE Phase 4 16-week study of Remodulin induction followed by oral…
United Therapeutics Announces Top Line Data From The EXPEDITE Study Of Remodulin Induction Prior To Orenitram Therapy
short induction of Remodulin® (treprostinil) injection allowed study subjects to reach double the typical doses of Orenitram® (treprostinil) extended-release tablets than patients who did not have a Remodulin